Maldives Food and Drug Authority (MFDA) has asked the public to be cautious following a quality issue with "Normal Immunoglobulin for IV," a medication manufactured in India.
In an announcement, MFDA stated that the World Health Organization (WHO) reported a quality concern in certain batches of this intravenous drug produced by the Indian pharmaceutical company Iko Biologicals.